SCHEMBL23761192

SCHEMBL23761192

CNN1CC2(CCNC2)C1

nearest known ligand 0.43

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.43
NAMPT P43490 1/20 0.31
L3MBTL3 Q96JM7 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24790634 0.86 TSHR (0.39) TSHR
SCHEMBL20715631 0.86 TSHR (0.51) TSHRNAMPTL3MBTL3L3MBTL1
SCHEMBL26309606 0.81
SCHEMBL3810524 0.75
SCHEMBL24790632 0.74 CYP2D6 (0.44) TSHR
SCHEMBL25788883 0.71 CYP1A2 (0.44) TSHR
SCHEMBL23182729 0.71 TSHR (0.30) TSHR
SCHEMBL17284523 0.70
SCHEMBL25045256 0.70
SCHEMBL20311322 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023114733-A1 KRAS MODULATORS AND USES THEREOF QUANTA THERAPEUTICS, INC. (US) 2023-06-22 WO disclosed
WO-2022261210-A1 KRAS MODULATORS AND USES THEREOF QUANTA THERAPEUTICS, INC. (US) 2022-12-15 WO disclosed
WO-2021160109-A1 DIHYDRONAPHTHYRIDINONE COMPOUND, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF 劲方医药科技(上海)有限公司 2021-08-19 WO disclosed